AI-based Cancer Screening and Precision Medicine

〈 Lunit Inc. 〉

This session will highlight the strategic importance of AI-based early cancer screening and precision medicine in advancing global health. Cancer remains one of the leading causes of mortality across APEC member economies, and early detection is a critical strategy for significantly improving treatment outcomes and survival rates. However, equity challenges persist due to variations in healthcare infrastructure among economies and regions.

The session will explore how AI technologies can enhance diagnostic accessibility, address shortages of skilled professionals, and improve cost-effectiveness throughout the cancer care continuum, including imaging diagnostics, pathology analysis, and prognosis prediction. It will feature examples of government-led AI screening initiatives and public–private collaboration in selected APEC economies, and provide an in-depth review of applicability in resource-constrained settings, ensuring data reliability, and addressing ethical and legal considerations. Through this dialogue, participants will exchange insights on how AI-driven cancer management models can generate public value within diverse healthcare systems.

(Speaker 1): Brandon B. Suh, MD, MPH, MBA

- Affiliation: Lunit Inc.

- Title: Chief Executive Officer

- Presentation Topic: "Transforming Global Cancer Care: Strategic Role of AI in Early Detection and Health Equity"

(internal note)

This presentation will focus on the macro-level impact of AI in cancer screening, emphasizing:

- The burden of cancer across APEC member economies and the urgency of early detection.

- How AI can bridge gaps in healthcare infrastructure and workforce capacities.

- Case studies of national-level AI screening programs and their outcomes.

- Strategic partnerships between governments, tech companies, and global health organizations.

- A vision for scalable, sustainable AI deployment in resource-constrained settings.

(Speaker 2): Jisu Ryu

- Affiliation: Lunit Inc.

- Title: Director, Product Management

- Presentation Topic: "AI in Action: Enhancing Diagnostic Accuracy and Accessibility Across the Cancer Care Continuum"

(internal note)

This presentation will address the technical and operational aspects of AI deployment, including:

- How AI models are trained and validated for medical imaging.

- Real-world implementation examples in hospitals and screening programs.

- Data reliability, ethical safeguards, and regulatory compliance.

- Product innovations designed for resource-constrained settings.

- Future roadmap for AI-powered precision medicine.

[9:30 - 9:35] Opening

[9:35 - 9:55] Speech 1 : "Transforming Global Cancer Care: Strategic Role of AI in Early Detection and Health Equity" (Brandon B. Suh, CEO of Lunit)

[9:55 - 10:15] Speech 2 : "AI in Action: Enhancing Diagnostic Accuracy and Accessibility Across the Cancer Care Continuum" (Jisu Ryu, Director at Lunit)

[10:15 - 10: 25] Coffee Break and Photo

[10:25 - 10:50] Q&A and Discussion 

[10:50] Closing